Big day tomorrow... stock price should jump a bit. Maybe a dollar or two on all the good news. Haven’t seen one hit article yet. Maybe it’s a moral issue to attack a drug that proves to save lives?

Could you imagine a short attack on a drug that just proved 24% life saving ability? What kind of morals would that show? Money over life saving? Would that be moral? I think not... all the media attention has been positive since Cytodyn released results Friday. A announcement tomorrow of a sale of Leronlimab might give us a spike. Could catch a few shorts with their pants down. Would love to see that. Just think... we have 4 or more countries that could end up buying some Leronlimab. Brazil, Philippines and Heath Canada and maybe even the MHRA have mentioned expedited use of Leronlimab.

Would be a great time to secure some Leronlimab with all the new variants and changing all the time. Can’t be to careful with not knowing how successful the vaccines are going to be or how long they will last. Some Leronlimab in your back pocket could go along way.